Delivery Order SPE2DB25D3008-SPE2DB25FRBMT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $5.54K delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price, non-competitive delivery order with performance completion targeted for July 14, 2025, and fulfillment from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of ORGOVYX 120 MG tablets in quantities of 30 units, with a contract ceiling value of $4,156.56. This non-competitive, firm fixed-price delivery order is set to conclude by July 31, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award utilized competitive procurement procedures with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52, represents a non-competitive, non-set-aside award and is set for completion by August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a ceiling value of $4,156.56 under a firm fixed-price contract. This non-competitive delivery order, issued on June 2, 2025, represents a single pharmaceutical procurement to be fulfilled by June 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for supply of ORGOVYX 120 MG tablets in quantities of 30s, valued at $6,927.60 with a firm fixed price structure and completion deadline of September 29, 2025. This delivery order represents a non-set-aside, competitively awarded procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for 30 tablets of ORGOVYX 120 mg, a pharmaceutical product supplied from the vendor's corporate office in Conshohocken, Pennsylvania. This non-competitive, firm fixed-price delivery order was awarded on July 16, 2025, with an ultimate completion date of August 6, 2025. The award represents a routine pharmaceutical supply transaction under AmerisourceBergen's existing federal contracting...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive award, with no set-aside designation, carries a ceiling value of $1,385.52 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 25, 2025. The award supports the federal government's pharmaceutical procurement needs through...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRBMTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 12, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $2,771.04 and completion targeted for April 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the awardee's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is executing this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's prime IDC vehicle, which supports comprehensive global pharmaceutical supply to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. ORGOVYX, a specialty pharmaceutical product, falls within the contract's scope of specialty medications and brand-name drugs supplied across multiple therapeutic domains. AmerisourceBergen's extensive federal contracting history and demonstrated capability in fulfilling DLA medical supply requirements through competitive awards underscore the company's role as a critical vendor for military and veteran healthcare logistics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 3/12/25 |